Estimating the impact of changes in HbA1c, body weight and insulin injection regimen on health related quality-of-life: a time trade off study

Health and Quality of Life Outcomes
M RidderstråleJ Jendle

Abstract

There are limited data on the potential short-term benefits associated with reductions in HbA1c levels, and understanding any immediate improvements in health related quality-of-life (HRQoL) through better glycaemic control may help inform diabetes management decisions. This time-trade-off (TTO) study investigated the short-term impact on HRQoL associated with three different aspects of diabetes management; HbA1c change, body weight change, and the complexity of treatment regimen. The study was designed in three stages: Stage 1) Qualitative telephone interviews with people with type 2 diabetes (T2D) in Denmark who had experienced a decrease in their HbA1c level. Stage 2) A validation survey with people with T2D in Denmark to obtain quantifiable knowledge on the short-term effects of a change in HbA1c levels. Stage 3) TTO survey using health states based on results from stage 2. Respondents were either adults with T2D (Sweden) or from the general public (UK and Denmark) and were separately asked to evaluate seven health states through an internet-based survey. Results from 4060 respondents were available for the TTO analysis (UK n = 1777; Denmark n = 1799, Sweden n = 484). 'Well-controlled diabetes' was associated with utilities...Continue Reading

References

Sep 30, 1993·The New England Journal of Medicine·UNKNOWN Diabetes Control and Complications Trial Research GroupC Siebert
Mar 1, 1996·Health Economics·P DolanA Williams
Sep 25, 1997·Social Science & Medicine·A RobinsonA Williams
Aug 10, 2001·Plastic and Reconstructive Surgery·W T ChangC L Kerrigan
Jul 24, 2002·Diabetologia·M Koopmanschap, UNKNOWN CODE-2 Advisory Board
Apr 27, 2005·The American Journal of Medicine·Richard R Rubin
Jan 9, 2008·Health and Quality of Life Outcomes·C Allyson JonesKenneth G Warren
Apr 1, 2002·Expert Review of Pharmacoeconomics & Outcomes Research·George W TorranceDavid Feeny
Oct 11, 2011·Current Medical Research and Opinion·Mette BøgelundMorten Lammert
Feb 9, 2012·Diabetic Medicine : a Journal of the British Diabetic Association·M PeyrotP-M Schumm-Draeger
Oct 12, 2013·Journal of Medical Economics·Marc EvansKamlesh Khunti
Jan 25, 2014·The Patient·R Brett McQueenJonathan D Campbell
Mar 5, 2014·Current Medical Research and Opinion·S LaneH Tildesley
May 9, 2014·International Journal of Environmental Research and Public Health·Aliasghar A KiadaliriKatarina Steen Carlsson
Jul 1, 2002·Diabetologia·M Koopmanschap

❮ Previous
Next ❯

Citations

Jun 24, 2017·International Journal of Circumpolar Health·N D RiedigerS G Bruce
Oct 12, 2018·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·Michael DempseyBarnaby Hunt
Mar 19, 2020·Archives of Endocrinology and Metabolism·Edilene Vieira PereiraAstrid Wiens
Oct 3, 2018·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·Ruey-Hsia WangShyi-Jang Shin
Oct 1, 2019·Primary Care Diabetes·Juan Pablo Sánchez de la CruzJosé Manuel Rodriguez-Perez
Nov 5, 2021·Journal of Medical Economics·Kristina S BoyeLaura Fernández Landó

❮ Previous
Next ❯

Software Mentioned

SAS®

Related Concepts

Related Feeds

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.